scholarly journals CD5-Positive Primary Cardiac Diffuse Large B-Cell Lymphoma: A Case Study

2013 ◽  
Vol 140 (suppl 1) ◽  
pp. A226-A226
Author(s):  
Aihong Liu ◽  
Ryan Gill
Keyword(s):  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Large B Cell Lymphoma ◽  
Large B Cell

scholarly journals Diffuse Large B-Cell Lymphoma Arising in Warthin's Tumor: Case Study and Review of the Literature

2013 ◽  
Vol 47 (6) ◽  
pp. 579 ◽  
Author(s):  
Güliz Özkök ◽  
Funda Taşlı ◽  
Nazan Özsan ◽  
Rafet Öztürk ◽  
Hakan Postacı
Keyword(s):  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Warthin’S Tumor ◽  
Review Of The Literature ◽  
Large B Cell Lymphoma ◽  
Warthin's Tumor ◽  
Large B Cell

Neurolymphomatosis: A Case Study of Diffuse Large B-Cell Lymphoma

2012 ◽  
Vol 16 (6) ◽  
pp. 636-637 ◽  
Author(s):  
Jessica N. Casselberry ◽  
Alan D. Kritz
Keyword(s):  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Large B Cell Lymphoma ◽  
Large B Cell

scholarly journals Adrenal Collision Tumor Composed of Pheochromocytoma and Diffuse Large B-Cell Lymphoma: A Case Report

2018 ◽  
Author(s):  
Atieh Khorsand ◽  
Fatemeh Khatami ◽  
Salma Sefidbakht ◽  
Hiva Saffar ◽  
Alireza Sadeghipour ◽  
...  
Keyword(s):  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Collision Tumor ◽  
Abdominal Discomfort ◽  
Histopathologic Study ◽  
Large B Cell Lymphoma ◽  
Adrenal Lymphoma ◽  
Large B Cell

Adrenal involvement in the course of malignant lymphoma occurs in about 4% of patients, but primary adrenal lymphoma (PAL) is extremely rare. To the best of our knowledge, only one case study reported the combination of PAL with pheochromocytoma. In the current study, we present the second case who was a 63-year-old man admitted to our hospital with hematuria and abdominal discomfort. Ultrasound imaging indicated the presence of a lesion, 5×4×3 cm in size, in the upper pole of his right kidney. Histopathologic study confirmed a collision tumor composed of pheochromocytoma and diffuse large B-cell lymphoma (DLBCL). Keywords: Collision tumor, Diffuse large B-cell lymphoma, Pheochromocytoma

Lymphome

Praxis ◽  
2016 ◽  
Vol 105 (1) ◽  
pp. 47-52 ◽  
Author(s):  
Andreas Lohri
Keyword(s):  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Staging System ◽  
Maligne Lymphome ◽  
Interim Pet ◽  
Large B Cell Lymphoma ◽  
Ann Arbor ◽  
Large B Cell

Zusammenfassung. Maligne Lymphome unterteilen sich zwar in über 60 Entitäten, das grosszellige B-Zell-Lymphom, das follikuläre Lymphom, der Hodgkin und das Mantelzell-Lymphom machen aber mehr als die Hälfte aller Lymphome aus. Im revidierten Ann Arbor staging system gelten die Suffixe «A» und «B» nur noch für den Hodgkin. «E» erscheint nur noch bei Stadien I und II. Eine Knochenmarksuntersuchung wird beim Hodgkin nicht mehr verlangt, beim DLBCL (Diffuse large B cell lymphoma) nur, falls das PET keinen Knochenmark-Befall zeigt. Der PET-Untersuchung, speziell dem Interim-PET, kommt eine entscheidende Bedeutung zu. PET-gesteuerte Therapien führen zu weniger Toxizität. Gezielt wirkende Medikamente mit eindrücklicher Wirksamkeit wurden neu zugelassen. Deren Kosten sind hoch. Eine strahlen- und chemotherapiefreie Behandlung maligner Lymphome wird in Zukunft möglich sein.

Sign in / Sign up

Export Citation Format

Share Document